Anticardiolipin antibodies, free protein S levels and thrombosis: A survey in a selected population of rheumatoid arthritis patients

Rheumatology

Volumn 38, Issue 7, 1999, Pages 675-678

  Seriolo, B ^a   Accardo, S ^a   Garnero, A ^a   Fasciolo, D ^a   Cutolo, M ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Anticardiolipin antibodies; Antithrombin III; Protein C; Protein S; Rheumatoid arthritis; Thrombotic events

Indexed keywords

ANTICOAGULANT PROTEIN; ANTITHROMBIN III; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S;

ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; THROMBOSIS; VEIN THROMBOSIS;

ADULT; AGED; ANTIBODIES, ANTICARDIOLIPIN; ANTITHROMBIN III; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; FEMALE; HUMANS; MIDDLE AGED; PROTEIN C; PROTEIN S; RISK FACTORS; THROMBOSIS;

EID: 0032706498     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/38.7.675     Document Type: Article

References (24)

1. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Intern Med 1990;112:682-98.
2. Harris EN. Antiphospholipid antibodies. Br J Haematol 1990;74:1-9.
3. Brey RL. Stroke prevention in patients with antiphospholipid antibodies. Lupus 1994;3:299-302.
4. Seriolo B, Cutolo M, Fasciolo D, Accardo S. Anticardiolipin antibodies in rheumatoid arthritis. [Letter] Ann Rheum Dis 1992;51:1100.
5. Fort JG, Cowchock FS, Abruzzo JL, Smith JB. Anticardiolipin antibodies in patients with rheumatic diseases. Arthritis Rheum 1987;30:752-60.
6. Merkel PA, Chang Y, Pierangeli SS, Convery K, Harris EN, Polisson RP. The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases. Am J Med 1996;101:576-83.
7. Parke AL, Weinstein RE, Bona RD, Maier DB, Walker FJ. The thrombotic diathesis associated with the presence of phospholipid antibodies may be due to low levels of free protein S. Am J Med 1992;93:49-56.
8. Crowther MA, Johnston M, Weitz J, Ginsberg JS. Free protein S deficiency may be found in patients with antiphospholipid antibodies who do not have systemic lupus erythematosus. Thromb Haemostasis 1996;76:689-91.
9. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24.
10. Seriolo B, Accardo S, Fasciolo D, Bertolini S, Cutolo M. Lipoprotein, anticardiolipin antibodies and thrombotic events in rheumatoid arthritis. Clin Exp Rheumatol 1996;14:593-9.
11. Thiagarajan P, Pengo V, Shapiro SS. The use of the dilute Russel viper venom time for the diagnosis of lupus anticoagulant. Blood 1986;68:869-74.
12. Schleider MA, Nachman RE, Jaffe EA, Coleman M. A clinical study of the lupus anticoagulant. Blood 1976; 48:499-509.
13. Proctor RR, Rapaport SI. The partial thromboplastin time with kaolin. J Clin Pathol 1961;36:212-9.
14. Martinoli JL, Stockner K. Fast functional protein C assay using Protac, a novel protein C activator. Thromb Res 1986;43:253-64.
15. Comp PC, Doray D, Patton D, Esmon CT. Abnormal plasma distribution of protein S occurs in functional protein S deficiency. Blood 1986;67:504-8.
16. Preda L, Tripodi A, Valsecchi C, Lombardi A, Finotti E, Manucci PM. A prothrombin time-based functional assay of protein S. Thromb Res 1990;60:19-32.
17. Lawrie AS, Lloyd ME, Mohamed F, Irons S, Hughes GR, Savidge GF. Assay of protein S in systemic lupus erythematosus. Blood Coag Fibrin 1995;46:322-4.
18. Tomas JF, Alberca I, Tabernaro MD, Cordero M, Dal Pino-Montes J, Vincente V. Natural anticoagulant proteins and antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol 1998;25:57-62.
19. Ginsberg JS, Demers C, Brill-Edwards P, Johnston M, Bona R, Burrows RF et al. Increased thrombin generation and activity in patients with systemic lupus erythematosus and anticardiolipin antibodies: evidence for a prothrombotic state. Blood 1993;81:2958-63.
20. Ginsberg JS, Demers C, Brill-Edwards P, Bone R, Johnston M, Wong A et al. Acquired free protein S deficiency is associated with antiphospholipid antibodies and increased thrombin generation in patients with systemic lupus erythematosus. Am J Med 1995;98:379-83.
21. Hughes GRV. The antiphospholipid syndrome: ten years on. Lancet 1993;342:341-4.
22. Comp PC, De Bault LE, Esmon NL, Esmon CT. Human thrombomodulin is inhibited by IgG from two patients with nonspecific anticoagulants. Blood 1983;62:299.
23. Freyssinet JM, Wiesel ML, Gaughy J, Boneu B, Cazenave JP. An IgM lupus anticoagulant that neutralizes the enhancing effect of phospholipid on purified endothelial thrombomodulin activity a mechanism of thrombosis. Thromb Haemostasis 1986;55:309-13.
24. Walker TS, Triplett DA, Javed N, Musgrave K. Evaluation of lupus anticoagulants: antiphospholipid antibodies, endothelium associated immunoglobulin, endothelial prostacyclin secretion, and antigenic protein S levels. Thromb Res 1988;51:267-81.